New Delhi: Pharmaceutical giant AstraZeneca has announced the global withdrawal of its Covid-19 vaccine. The company cited a surplus of newer vaccine options as the primary reason behind this decision.
AstraZeneca has voluntarily withdrawn the “marketing authorization” for the vaccine within the European Union, with similar applications expected to be made in other countries where the vaccine was previously approved.
This decision comes amidst ongoing legal battles faced by AstraZeneca, including allegations linking its vaccine, developed in collaboration with the University of Oxford, to fatalities and severe injuries, notably Thrombosis with Thrombocytopenia Syndrome (TTS).
However, the company has clarified that the withdrawal is not directly linked to ongoing court cases or its admission of TTS side effects. Instead, AstraZeneca attributed the decision to commercial reasons and a decline in demand for the vaccine.
“As multiple variant Covid-19 vaccines have since been developed, there is a surplus of available updated vaccines,” stated AstraZeneca in a released statement.
Mumbai: Legendary playback singer Asha Bhosle passed away at the age of 93 in Mumbai…
Bhubaneswar: Amid concerns over global geo-political developments and their potential impact on energy supplies, the…
Bhubaneswar: In a seasonal conservation measure, the Odisha government has imposed a ban on sea…
Baripada: A vast deposit of prehistoric marine fossils along the Budha Balanga river near Baripada…
Bhubaneswar: The Odisha Cabinet, chaired by Chief Minister Mohan Charan Majhi, on Friday approved a…
Bhubaneswar: In a focused effort to create livelihood opportunities in forest regions, the Odisha government…
